Use of Hydrochlorothiazide and Risk of Melanoma and Nonmelanoma Skin Cancer

ConclusionsUse of hydrochlorothiazide was associated with an increased risk of cSCC and with evidence of a duration – and dose–response relationship. In contrast, no association was observed for BCC or melanoma.

Source: Drug Safety - October 26, 2020 Category: Drugs & Pharmacology Source Type: research